Hardide (HDD): Corp Interim results | Ideagen (IDEA): Corp Strong and consistent – full-year trading update | Shield Therapeutics (STX): Corp Europe underpins current valuation; await US approval | Tekcapital (TEK): Corp Launch of new eyewear line
14 May 2019
Morning Note – 14 May 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 14 May 2019
- Published:
14 May 2019 -
Author:
Andrew Darley | David Buxton | Mark Paddon | Mark Brewer -
Pages:
7
Hardide (HDD): Corp Interim results | Ideagen (IDEA): Corp Strong and consistent – full-year trading update | Shield Therapeutics (STX): Corp Europe underpins current valuation; await US approval | Tekcapital (TEK): Corp Launch of new eyewear line